You just read:

RXi Pharmaceuticals to Present New Data from its Immuno-Oncology Program Using sd-rxRNA Therapeutic Compounds Targeting Intracellular Checkpoint Cbl-b in NK Cells at the 16th Annual Discovery on Target Conference

News provided by

RXi Pharmaceuticals Corporation

Sep 26, 2018, 08:00 ET